Changes in the metabolic footprint of placental explant-conditioned culture medium identifies metabolic disturbances related to hypoxia and pre-eclampsia.
暂无分享,去创建一个
D. Kell | W. Dunn | I. Crocker | D. Broadhurst | P. Baker | L. Kenny | A. Heazell | M. Brown | S. Worton | R. Horgan | I. Crocker | W. Dunn | Alexander E. P. Heazell | Philip N. Baker | David Broadhurst | Richard P. Horgan | Louise C. Kenny | Douglas B. Kell | D. B. Kell | D. Kell | D. Broadhurst | A. Heazell
[1] D. Kell,et al. Mass Spectrometry Tools and Metabolite-specific Databases for Molecular Identification in Metabolomics , 2009 .
[2] Joshua D. Knowles,et al. Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. , 2009, Analytical chemistry.
[3] D. Kell,et al. Analysis of the metabolic footprint and tissue metabolome of placental villous explants cultured at different oxygen tensions reveals novel redox biomarkers. , 2008, Placenta.
[4] D. Kell,et al. Detection and Identification of Novel Metabolomic Biomarkers in Preeclampsia , 2008, Reproductive Sciences.
[5] J. Kiang,et al. Inhibition of Inducible Nitric-Oxide Synthase Protects Human T Cells from Hypoxia-Induced Apoptosis , 2008, Molecular Pharmacology.
[6] Terry J. Smith,et al. Expression Levels of mRNA for Rho A/Rho Kinase and Its Role in Isoprostane-Induced Vasoconstriction of Human Placental and Maternal Vessels , 2008, Reproductive Sciences.
[7] I. Crocker,et al. Effects of oxygen on cell turnover and expression of regulators of apoptosis in human placental trophoblast. , 2008, Placenta.
[8] I. Crocker,et al. Oxygen and the liberation of placental factors responsible for vascular compromise , 2008, Laboratory Investigation.
[9] N. Serkova,et al. Metabolic Markers of Hypoxia: Systems Biology Application in Biomedicine , 2008, Toxicology mechanisms and methods.
[10] I. Crocker,et al. Formation of syncytial knots is increased by hyperoxia, hypoxia and reactive oxygen species. , 2007, Placenta.
[11] P. Sedlmayr. Indoleamine 2,3-dioxygenase in materno-fetal interaction. , 2007, Current drug metabolism.
[12] A. Toker,et al. Placental tissue cyclo‐oxygenase 1 and 2 in pre‐eclamptic and normal pregnancy , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[13] J. Kingdom,et al. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.
[14] S. Yeh,et al. Effect of physiologic levels of glutamine on ICAM-1 expression in endothelial cells activated by preeclamptic plasma. , 2006, The Journal of reproductive medicine.
[15] C. Yeh,et al. Effect of glutamine on cell adhesion molecule expression and leukocyte transmigration in endothelial cells stimulated by preeclamptic plasma. , 2005, Nutrition.
[16] Douglas B. Kell,et al. Novel biomarkers for pre-eclampsia detected using metabolomics and machine learning , 2005, Metabolomics.
[17] D. Kell,et al. Metabolic footprinting and systems biology: the medium is the message , 2005, Nature Reviews Microbiology.
[18] B Huppertz,et al. Human placental explants in culture: approaches and assessments. , 2005, Placenta.
[19] I. Sargent,et al. Latest Advances in Understanding Preeclampsia , 2005, Science.
[20] R. Ness,et al. Early Occurrence of Metabolic Syndrome After Hypertension in Pregnancy , 2005, Obstetrics and gynecology.
[21] G. Mires,et al. In Preeclampsia, the Circulating Factors Capable of Altering In Vitro Endothelial Function Precede Clinical Disease , 2005, Hypertension.
[22] F. Prefumo,et al. OC065: Uterine artery resistance at 10–14 weeks of gestation is correlated with trophoblast apoptosis , 2004 .
[23] D. Kell,et al. Metabolomics by numbers: acquiring and understanding global metabolite data. , 2004, Trends in biotechnology.
[24] J. Kingdom,et al. Pre-eclampsia : Current Perspectives on Management , 2003 .
[25] T. Libermann,et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. , 2003, The Journal of clinical investigation.
[26] I. Sargent,et al. Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia. , 2003, American journal of obstetrics and gynecology.
[27] I. Crocker,et al. Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. , 2003, The American journal of pathology.
[28] T. Lawrence,et al. Anti-inflammatory lipid mediators and insights into the resolution of inflammation , 2002, Nature Reviews Immunology.
[29] D. Sahota,et al. Increased placental apoptosis in pregnancies complicated by preeclampsia. , 2001, American journal of obstetrics and gynecology.
[30] I. Sargent,et al. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre‐eclamptic pregnancies , 1998, British journal of obstetrics and gynaecology.
[31] V. Gujrati,et al. Novel appearance of placental nuclear monoamine oxidase: biochemical and histochemical evidence for hyperserotonomic state in preeclampsia-eclampsia. , 1996, American journal of obstetrics and gynecology.
[32] J. Sun,et al. [Determination of serum free amino acids and ammonia in pregnant women with severe pregnancy induced hypertension]. , 1996, Zhonghua fu chan ke za zhi.
[33] W. Vach,et al. [Changes in serotonin metabolism in pre-eclampsia]. , 1996, Geburtshilfe und Frauenheilkunde.
[34] T. Imai,et al. [Quantitative changes in leukotriene B4 release in neutrophilic leukocytes activated by Ca ionophore during pregnancy--normal pregnancy and preeclampsia]. , 1996, Nihon Sanka Fujinka Gakkai zasshi.
[35] L. Dinkelborg,et al. Transport and metabolism of L-glutamate during oxygenation, anoxia, and reoxygenation of rat cardiac myocytes. , 1996, The American journal of physiology.
[36] R. Pijnenborg,et al. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre‐eclamptic pregnancies , 1994, British journal of obstetrics and gynaecology.
[37] W. Piering,et al. Preeclampsia related to a functioning extrauterine placenta: report of a case and 25-year follow-up. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[38] A. Koller,et al. Prostaglandins mediate arteriolar dilation to increased blood flow velocity in skeletal muscle microcirculation. , 1990, Circulation research.
[39] I. Macgillivray,et al. The classification and definition of the hypertensive disorders of pregnancy. , 1988, American journal of obstetrics and gynecology.
[40] R. A. Coleman,et al. Comparison of the potencies of some prostaglandins as vasodilators in three vascular beds of the anaesthetised dog. , 1982, European journal of pharmacology.
[41] E. Norwitz. Defective implantation and placentation: laying the blueprint for pregnancy complications. , 2007, Reproductive biomedicine online.
[42] D. Kell,et al. Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.
[43] D. Walker,et al. Regional changes in kynurenic acid, quinolinic acid, and glial fibrillary acidic protein concentrations in the fetal sheep brain after experimentally induced placental insufficiency. , 2001, American journal of obstetrics and gynecology.
[44] E. Morel,et al. Observations on 138 molar pregnancies. , 1969, American journal of obstetrics and gynecology.